Control of morbillivirus replication by RNAI

Servan de Almeida Renata, Keita D., Libeau Geneviève, Albina Emmanuel. 2007. Control of morbillivirus replication by RNAI. In : Does control of animal infectious risks offer a new international perspective ? : proceedings of the 12th International Conference of the Association of Institutions of Tropical Veterinary Medicine, Montpellier, France, 20-22 August 2007. Camus Emmanuel (ed.), Cardinale Eric (ed.), Dalibard Christophe (ed.), Martinez Dominique (ed.), Renard Jean-François (ed.), Roger François (ed.). CIRAD. Montpellier : CIRAD, pp. 175-181. ISBN 978-2-87614-650-1 International Conference of the Association of Institutions of Tropical Veterinary Medicine. 12, Montpellier, France, 20 August 2007/22 August 2007.

Paper without proceedings
Published version - Anglais
Use under authorization by the author or CIRAD.

Télécharger (1MB) | Preview

Abstract : The Morbillivirus genus includes measles virus (MV), peste des petits ruminants virus (PPRV) and rinderpest virus (RPV). Although preventive vaccines are available against these three viruses, efficient therapeutics for virus control under emergency situations are desirable. Inhibition of morbillivirus replication can be achieved by post-transcriptional silencing of the nucleoprotein (N) gene by RNA interference (RNAi). The viral N protein, a well conserved protein among the genus, plays a central role in the replication of the virus. Using a comprehensive siRNA-based screening of the conserved sequences of the N gene, we have identified, three common positions on the N gene, for the design of siRNA evenly effectives for PPRV, RPV and MV. siRNA silencing resulted in more than 80% decrease of the viral replication in infected Vero cell, as shown by real-time quantitative PCR, flow cytometry and virus titration. In a second step, a recombinant replication-defective human type 5 adenovirus (Ad-5) encoding one of the functional sequences directed against the N gene of PPRV was constructed and shown to reduce the PPRV replication in vitro. These results illustrate that adenovirus vector could be a promising candidate for the development of siRNA antiviral treatments against morbilliviruses.

Classification Agris : L73 - Animal diseases

Auteurs et affiliations

  • Servan de Almeida Renata, CIRAD-BIOS-UPR Contrôle des maladies (FRA)
  • Keita D.
  • Libeau Geneviève, CIRAD-BIOS-UPR Contrôle des maladies (FRA)
  • Albina Emmanuel, CIRAD-BIOS-UPR Contrôle des maladies (FRA)

Autres liens de la publication

Source : Cirad - Agritrop (

View Item (staff only) View Item (staff only)

[ Page générée et mise en cache le 2019-10-07 ]